123 related articles for article (PubMed ID: 104180)
1. Determination of the minimal inhibitory concentration of amphotericin B and miconazole for 21 strains of Aspergillus.
Martinez J; Torres JM; Arteaga F; Foz-Tena A
Mycopathologia; 1978 Nov; 64(3):147-51. PubMed ID: 104180
[TBL] [Abstract][Full Text] [Related]
2. In vitro comparison of the antifungal activities of R34,000, miconazole and amphotericin B.
Dixon DM; Wagner GE; Shadomy S; Shadomy HJ
Chemotherapy; 1978; 24(6):364-7. PubMed ID: 699677
[TBL] [Abstract][Full Text] [Related]
3. Discrepancies between MIC and MLC values of amphotericin B against isolates of Aspergillus species.
Colombo AL; McGough DA; Rinaldi MG
Mycopathologia; 1994 Dec; 128(3):129-33. PubMed ID: 7739726
[TBL] [Abstract][Full Text] [Related]
4. MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp.
Schmitt HJ; Bernard EM; Andrade J; Edwards F; Schmitt B; Armstrong D
Antimicrob Agents Chemother; 1988 May; 32(5):780-1. PubMed ID: 3134851
[TBL] [Abstract][Full Text] [Related]
5. Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999.
Chandrasekar PH; Cutright JL; Manavathu EK
Diagn Microbiol Infect Dis; 2001 Dec; 41(4):211-4. PubMed ID: 11777662
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of environmental versus clinical strains of pathogenic Aspergillus.
Araujo R; Pina-Vaz C; Rodrigues AG
Int J Antimicrob Agents; 2007 Jan; 29(1):108-11. PubMed ID: 17189101
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity to 5-fluorocytosine and virulence for mice of some human isolates of Aspergillus.
Nobre G
Mycopathologia; 1977 Nov; 62(1):57-60. PubMed ID: 413042
[TBL] [Abstract][Full Text] [Related]
8. Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis.
Moosa MY; Alangaden GJ; Manavathu E; Chandrasekar PH
J Antimicrob Chemother; 2002 Jan; 49(1):209-13. PubMed ID: 11751792
[TBL] [Abstract][Full Text] [Related]
9. [In vitro comparative study of the sensitivity of Aspergillus to antifungal agents].
Guinet R; Mazoyer MA
Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):654-7. PubMed ID: 6462761
[TBL] [Abstract][Full Text] [Related]
10. Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.
Paterson PJ; Seaton S; Prentice HG; Kibbler CC
J Antimicrob Chemother; 2003 Nov; 52(5):873-6. PubMed ID: 14519673
[TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of the new triazole D0870 compared with amphotericin B and itraconazole against Aspergillus spp.
Moore CB; Law D; Denning DW
J Antimicrob Chemother; 1993 Dec; 32(6):831-6. PubMed ID: 8144422
[TBL] [Abstract][Full Text] [Related]
12. Surveillance for azoles resistance in Aspergillus spp. highlights a high number of amphotericin B-resistant isolates.
Reichert-Lima F; Lyra L; Pontes L; Moretti ML; Pham CD; Lockhart SR; Schreiber AZ
Mycoses; 2018 Jun; 61(6):360-365. PubMed ID: 29468746
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. acquired resistance to itraconazole.
Chryssanthou E
Scand J Infect Dis; 1997; 29(5):509-12. PubMed ID: 9435042
[TBL] [Abstract][Full Text] [Related]
14. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
Warn PA; Morrissey G; Morrissey J; Denning DW
J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
[TBL] [Abstract][Full Text] [Related]
15. Single-dose pharmacodynamics of amphotericin B against Aspergillus species in an in vitro pharmacokinetic/pharmacodynamic model.
Al-Saigh R; Siopi M; Siafakas N; Velegraki A; Zerva L; Meletiadis J
Antimicrob Agents Chemother; 2013 Aug; 57(8):3713-8. PubMed ID: 23716054
[TBL] [Abstract][Full Text] [Related]
16. Effect of methotrexate on the germination and growth of Aspergillus fumigatus and Aspergillus flavus strains.
Warnock DW; Oliver DA; Cheung MM; Zurick NJ
J Antimicrob Chemother; 1992 Apr; 29(4):375-81. PubMed ID: 1607326
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).
Manavathu EK; Cutright JL; Loebenberg D; Chandrasekar PH
J Antimicrob Chemother; 2000 Aug; 46(2):229-34. PubMed ID: 10933645
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the in vitro activity of amphotericin B against Aspergillus spp. by tetracycline analogs.
Hughes CE; Harris C; Peterson LR; Gerding DN
Antimicrob Agents Chemother; 1984 Dec; 26(6):837-40. PubMed ID: 6524900
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of inactivation of Asperigillus flavus and Aspergillus terreus conidiospores by amphotericin B in the presence of serum.
Mbakwem CE; Mathison GE
J Appl Bacteriol; 1979 Apr; 46(2):317-23. PubMed ID: 110762
[No Abstract] [Full Text] [Related]
20. Comparison of azoles against aspergilli in vitro and in an experimental model of pulmonary aspergillosis.
Schmitt HJ; Edwards F; Andrade J; Niki Y; Armstrong D
Chemotherapy; 1992; 38(2):118-26. PubMed ID: 1317280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
